Home›Mirtazapine

Mirtazapine

Also known as: Remeron, Mirataz

Route: Oral

Check Mirtazapine Interactions →
50 interactions on record⛔ Black Box Warning

Mirtazapine has 50 known drug interactions based on U.S. FDA drug labeling data. Of these, 7 are contraindicated combinations that should be avoided entirely. 27 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Isocarboxazid, Linezolid, Methylene Blue. Patients taking Mirtazapine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
50
Contraindicated
7
Major
27
Moderate
16

Contraindicated (7)

  • Mirtazapine + Isocarboxazid— Concomitant use increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking MAOIs.
  • Mirtazapine + Linezolid— Concomitant use increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking this MAOI.
  • Mirtazapine + Methylene Blue— Intravenous methylene blue increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking this …
  • Mirtazapine + Monoamine Oxidase Inhibitors (Maois)— Monoamine Oxidase Inhibitors are contraindicated with mirtazapine; see contraindications, warnings, and dosage sections.
  • Mirtazapine + Phenelzine— Concomitant use increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking MAOIs.
  • Mirtazapine + Selegiline— Concomitant use increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking MAOIs.
  • Mirtazapine + Tranylcypromine— Concomitant use increases risk of serotonin syndrome. Mirtazapine is contraindicated in patients taking MAOIs.

Major (27)

Moderate (16)

  • Mirtazapine + Alcohol— Concomitant use increases impairment of cognitive and motor skills. Avoid concomitant use.
  • Mirtazapine + Alprazolam— Benzodiazepine increases impairment of cognitive and motor skills. Avoid concomitant use.
  • Mirtazapine + Azole Antifungals— Azole antifungals are potent CYP3A4 inhibitors that may increase mirtazapine concentrations. Caution should be exercised…
  • Mirtazapine + Butorphanol Tartrate— Concomitant use may result in serotonin syndrome; monitor regularly during initiation and dose adjustment.
  • Mirtazapine + Carbamazepine— Strong CYP3A inducer decreases mirtazapine plasma concentration. May require dose increase.
  • Mirtazapine + Cimetidine— CYP1A2, CYP2D6, and CYP3A inhibitor may increase mirtazapine plasma concentration. May require dose decrease.
  • Mirtazapine + Erythromycin— Caution should be exercised when coadministering mirtazapine with potent CYP3A4 inhibitors, HIV protease inhibitors, azo…
  • Mirtazapine + Itraconazole— Strong CYP3A inhibitor may increase mirtazapine plasma concentration. May require dose decrease.
  • Mirtazapine + Ketoconazole— Ketoconazole increases mirtazapine peak plasma levels by approximately 40% and AUC by 50%. Caution should be exercised w…
  • Mirtazapine + Nefazodone— Strong CYP3A inhibitor may increase mirtazapine plasma concentration. May require dose decrease.
  • Mirtazapine + Nitrazepam— Concomitant use increases impairment of cognitive and motor skills. Avoid concomitant use.
  • Mirtazapine + Phenytoin— Strong CYP3A inducer decreases mirtazapine plasma concentration. May require dose increase.
  • Mirtazapine + Protease Inhibitors— HIV protease inhibitors are potent CYP3A4 inhibitors that may increase mirtazapine concentrations. Caution should be exe…
  • Mirtazapine + Rifampin— Strong CYP3A inducer decreases mirtazapine plasma concentration. May require dose increase.
  • Mirtazapine + Ritonavir— Strong CYP3A inhibitor may increase mirtazapine plasma concentration. May require dose decrease.
  • Mirtazapine + Warfarin— Monitor INR during concomitant use with mirtazapine.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations